Drug Shortage Report for TAMIFLU

Last updated on 2026-01-06

Report ID 275242
Drug Identification Number 02381842
Brand name TAMIFLU
Common or Proper name Oseltamivir
Company Name HOFFMANN-LA ROCHE LIMITED
Market Status MARKETED
Active Ingredient(s) OSELTAMIVIR
Strength(s) 6MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 6mg / mL
ATC code J05AH
ATC description DIRECT ACTING ANTIVIRALS
Reason for shortage Demand increase for the drug.
Anticipated start date 2026-01-02
Actual start date 2026-01-09
Estimated end date 2026-02-20
Actual end date
Shortage status Actual shortage
Updated date 2026-01-06
Company comments There has been a significant increase in demand due to the spread of influenza in Canada. There have also been shortages in the market that have led to a greater uptick in demand for this product from Roche. Therefore, we are implementing an allocation of stock until we are able to obtain a resupply in the coming weeks. Tamiflu 75mg capsules remain available for compounding a suspension should the powder for suspension be unavailable. Refer to the product monograph for compounding instructions.
Health Canada comments
Tier 3 Status No
Contact Address 7070 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 5M8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v16 2026-01-13 English Compare
v15 2026-01-06 French Compare
v14 2026-01-06 English Compare
v13 2026-01-06 French Compare
v12 2026-01-06 English Compare
v11 2026-01-06 English Compare
v10 2026-01-05 French Compare
v9 2026-01-05 English Compare
v8 2026-01-05 English Compare
v7 2026-01-05 English Compare
v6 2026-01-05 French Compare
v5 2026-01-05 English Compare
v4 2026-01-05 English Compare
v3 2026-01-05 English Compare
v2 2026-01-05 English Compare
v1 2026-01-05 English Compare

Showing 1 to 16 of 16